Literature DB >> 9705104

The role of thrombolytic therapy in the management of paradoxical embolism.

A d'Audiffret1, S S Shenoy, J J Ricotta, M Dryjski.   

Abstract

Paradoxical emboli are considered a rare event, representing less than 2% of all arterial emboli. The most common intracardiac defect associated with paradoxical emboli is a patent foramen ovale. Most commonly, a pulmonary embolism is the cause of the acute increase in right atrial pressure leading to a reversal of intracardiac flow and passage of venous embolic material to the left heart. We present a patient with a pulmonary embolism and paradoxical emboli, and discuss therapeutic approach. We suggest that the treatment of choice for the patient with pulmonary embolism and non-limb-threatening acute ischemia due to a paradoxical emboli should be thrombolytic therapy and intracaval filter placement, followed by patent foramen ovale repair.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705104     DOI: 10.1016/s0967-2109(97)00154-3

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  4 in total

1.  Paradoxical embolism: Experiences from a single center.

Authors:  Hong-Liang Zhang; Zhi-Hong Liu; Qin Luo; Yong Wang; Zhi-Hui Zhao; Chang-Ming Xiong
Journal:  Chronic Dis Transl Med       Date:  2017-03-30

2.  Paradoxical embolism after surgery for breast cancer: a case report.

Authors:  Zhimin Yu; Heran Deng; Jie Wang; Junyao Xu
Journal:  BMC Surg       Date:  2020-07-08       Impact factor: 2.102

3.  Lower limb vein thrombosis-induced pulmonary embolism and paradoxical multiple arterial embolisms: A case report with a 10-year follow-up.

Authors:  Guang Huang; Yu Tang; Hailiang Wang; Rong Xiong; Ainan Xu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  Multiorgan paradoxical embolism consequent to acute pulmonary thromboembolism with patent foramen ovale: a case report.

Authors:  Giorgio Caretta; Debora Robba; Ivano Bonadei; Melissa Teli; Benedetta Fontanella; Enrico Vizzardi; Davide Farina; Riccardo Raddino; Livio Dei Cas
Journal:  Cases J       Date:  2009-09-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.